Eli Lilly is offering vials of its obesity drug Zepbound to patients at a discount — but only if they skip their insurance.

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. (Shelby Knowles/Bloomberg via / Getty Images ...

Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, announced Wednesday ... that has helped people with obesity. - Image: UCG / Contributor (Getty Images) A group that ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

James Manning/PA Images via Getty Images ... now also offer consumers who lack insurance coverage the option to buy Zepbound and Wegovy, respectively, on direct-to-consumer platforms at a lower ...

(Photo by Ed Zurga/Getty Images) Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish drugmaker Novo Nordisk said Wednesday that it ...

ELI LILLY CUTS PRICES FOR ZEPBOUND WEIGHT-LOSS DRUG AGAIN Those ... (Carsten Snejbjerg/Bloomberg via / Getty Images) The company said its offering came shortly after the Food and Drug ...

Image source: Getty Images ... VK2735, like Lilly's tirzepatide -- the active compound in Mounjaro and Zepbound -- is a dual GIP/GLP-1 receptor agonist. It acts on hormonal pathways involved ...

(Carsten Snejbjerg/Bloomberg via / Getty Images) The company said its offering ... supply and cutting the costs of its weight-loss drug Zepbound, again, effectively broadening access to more ...

dpa/picture alliance via Getty Images “I was devastated,” he said ... Wegovy, Mounjaro and Zepbound. Norris at his current weight of 230 pounds and off the Mounjaro. He has NAION in ...

Cristina Arias / Cover / Getty Images Roche moved to enter the booming ... Nordisk’s Ozempic and Wegovy and Lilly's Mounjaro and Zepbound. Roche to Pay Zealand Up to $5.3B Roche will pay Zealand ...

Getty Images/iStockphoto Veru ... and in combination with Zepbound, and will complete a study with Novo’s Wegovy begun prior to the 2023 acquisition. “I think to really show a benefit for ...